These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36814805)

  • 1. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma.
    Hu X; Wang Q; Huang G; He X; Sparrelid E; Brismar TB; Fan Y
    Comput Math Methods Med; 2023; 2023():5424204. PubMed ID: 36814805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
    Chen Y; Chen J; Zhang Y; Lin Z; Wang M; Huang L; Huang M; Tang M; Zhou X; Peng Z; Huang B; Feng ST
    J Hepatocell Carcinoma; 2021; 8():795-808. PubMed ID: 34327180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomics model based on magnetic resonance imaging to predict cytokeratin 7/19 expression and liver fluke infection of hepatocellular carcinoma.
    Liu JQ; Wang J; Huang XL; Liang TY; Zhou X; Mo ST; Xie HX; Yang KJ; Zhu GZ; Su H; Liao XW; Long LL; Peng T
    Sci Rep; 2023 Oct; 13(1):17553. PubMed ID: 37845287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
    Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radiomics nomogram for predicting cytokeratin 19-positive hepatocellular carcinoma: a two-center study.
    Zhang L; Zhou H; Zhang X; Ding Z; Xu J
    Front Oncol; 2023; 13():1174069. PubMed ID: 37182122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic radiomics based on contrast-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma.
    Zhang R; Wang Y; Li Z; Shi Y; Yu D; Huang Q; Chen F; Xiao W; Hong Y; Feng Z
    BMC Med Imaging; 2024 Apr; 24(1):80. PubMed ID: 38584254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.
    Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN
    Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study.
    Yang F; Wan Y; Xu L; Wu Y; Shen X; Wang J; Lu D; Shao C; Zheng S; Niu T; Xu X
    Front Oncol; 2021; 11():672126. PubMed ID: 34476208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.
    Huang X; Long L; Wei J; Li Y; Xia Y; Zuo P; Chai X
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2995-3003. PubMed ID: 31664520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
    Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
    Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiomics model based on preoperative gadoxetic acid-enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.
    Li C; Wang Q; Zou M; Cai P; Li X; Feng K; Zhang L; Sparrelid E; Brismar TB; Ma K
    Front Oncol; 2023; 13():1164739. PubMed ID: 37476376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
    Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of MRI in predicting hepatocellular carcinoma with cytokeratin 19 expression: a systematic review and meta-analysis.
    Qin Q; Deng LP; Chen J; Ye Z; Wu YY; Yuan Y; Song B
    Clin Radiol; 2023 Dec; 78(12):e975-e984. PubMed ID: 37783612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Chen X; Chen Y; Chen H; Zhu J; Huang R; Xie J; Zhang T; Xie A; Li Y
    Abdom Radiol (NY); 2023 Aug; 48(8):2525-2536. PubMed ID: 37169988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction for Aggressiveness and Postoperative Recurrence of Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
    Lu M; Qu Q; Xu L; Zhang J; Liu M; Jiang J; Shen W; Zhang T; Zhang X
    Acad Radiol; 2023 May; 30(5):841-852. PubMed ID: 36577606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.